The North America Recombinant Proteins Market would witness market growth of 10.3% CAGR during the forecast period (2022-2028).
Today, a range of recombinant proteins, such as those utilised in medical therapies, are produced using various bioprocessing processes. In the recombinant protein market, worldwide, for instance, vaccinations are produced using recombinant DNA technology to help prevent the spread of illnesses. It can also be utilized to make pharmaceuticals and other healthcare products. Utilizing recombinant protein has numerous advantages. One benefit is that recombinant protein products are more precise and reliable than those produced using conventional techniques.
In September 2020, GigaGen Inc. began mass manufacture of its first-in-class recombinant hyperimmune medication GIGA-2050 for the treatment of COVID-19 in association with Waisman Biomanufacturing and Goodwin Biotechnology Inc.
Due to rising research spending, a developed healthcare system, and a number of significant market players, North America is predicted to lead the recombinant protein market. Recombinant proteins are one of the tried-and-true treatments for the chronic diseases that are becoming more prevalent throughout the region, which is driving up demand for recombinant protein therapies. Effective therapies are required due to the rising incidence of cancer.
The US market dominated the North America Recombinant Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $708.8 million by 2028. The Canada market is poised to grow at a CAGR of 12.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 11.8% during (2022 - 2028).
Based on Product, the market is segmented into Growth Factors & Chemokines, Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors, Structural Proteins, Membrane Proteins, Kinase Proteins & Regulatory Proteins, Immune Response Proteins, and Others. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Recombinant Proteins Market is Predict to reach $2.6 Billion by 2028, at a CAGR of 10.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Growth Factors & Chemokines
- Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
- Structural Proteins
- Membrane Proteins
- Kinase Proteins & Regulatory Proteins
- Immune Response Proteins
- Others
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Others
By Application
- Drug Discovery & Development
- Academic Research Studies
- Biopharmaceutical Production
- Diagnostics
- Biotechnology Research
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Bio-Techne Corporation
- Thermo Fisher Scientific, Inc.
- Merck Group
- Bio-Rad Laboratories, Inc.
- Abcam plc
- Genscript Biotech Corporation
- Miltenyi Biotec B.V. & Co. KG
- Proteintech Group, Inc.
- BPS Bioscience, Inc.
- RayBiotech Life, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Recombinant Proteins Market, by Product
1.4.2 North America Recombinant Proteins Market, by End User
1.4.3 North America Recombinant Proteins Market, by Application
1.4.4 North America Recombinant Proteins Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Recombinant Proteins Market
Chapter 4. North America Recombinant Proteins Market by Product
4.1 North America Growth Factors & Chemokines Market by Country
4.2 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
4.3 North America Structural Proteins Market by Country
4.4 North America Membrane Proteins Market by Country
4.5 North America Kinase Proteins & Regulatory Proteins Market by Country
4.6 North America Immune Response Proteins Market by Country
4.7 North America Others Market by Country
Chapter 5. North America Recombinant Proteins Market by End User
5.1 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
5.2 North America Biotechnology Companies Market by Country
5.3 North America Academic Research Institutes Market by Country
5.4 North America Contract Research Organizations Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Recombinant Proteins Market by Application
6.1 North America Drug Discovery & Development Market by Country
6.2 North America Academic Research Studies Market by Country
6.3 North America Biopharmaceutical Production Market by Country
6.4 North America Diagnostics Market by Country
6.5 North America Biotechnology Research Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Recombinant Proteins Market by Country
7.1 US Recombinant Proteins Market
7.1.1 US Recombinant Proteins Market by Product
7.1.2 US Recombinant Proteins Market by End User
7.1.3 US Recombinant Proteins Market by Application
7.2 Canada Recombinant Proteins Market
7.2.1 Canada Recombinant Proteins Market by Product
7.2.2 Canada Recombinant Proteins Market by End User
7.2.3 Canada Recombinant Proteins Market by Application
7.3 Mexico Recombinant Proteins Market
7.3.1 Mexico Recombinant Proteins Market by Product
7.3.2 Mexico Recombinant Proteins Market by End User
7.3.3 Mexico Recombinant Proteins Market by Application
7.4 Rest of North America Recombinant Proteins Market
7.4.1 Rest of North America Recombinant Proteins Market by Product
7.4.2 Rest of North America Recombinant Proteins Market by End User
7.4.3 Rest of North America Recombinant Proteins Market by Application
Chapter 8. Company Profiles
8.1 Bio-Techne Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Abcam plc
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Genscript Biotech Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expenses
8.7 Miltenyi Biotech B.V. & Co. KG
8.7.1 Company Overview
8.8 Proteintech Group, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 BPS Bioscience, Inc.
8.9.1 Company Overview
8.10. RayBiotech Life, Inc.
8.10.1 Company Overview
TABLE 1 North America Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 2 North America Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 3 North America Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 4 North America Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 5 North America Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Structural Proteins Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Structural Proteins Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Membrane Proteins Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Membrane Proteins Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Immune Response Proteins Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Immune Response Proteins Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 20 North America Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 21 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Academic Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Academic Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 32 North America Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 33 North America Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Academic Research Studies Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Academic Research Studies Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Biotechnology Research Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Biotechnology Research Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Recombinant Proteins Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Recombinant Proteins Market by Country, 2022 - 2028, USD Million
TABLE 47 US Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 48 US Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 49 US Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 50 US Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 51 US Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 52 US Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 53 US Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 54 US Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 55 Canada Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 56 Canada Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 57 Canada Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 58 Canada Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 59 Canada Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 60 Canada Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 61 Canada Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 62 Canada Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 63 Mexico Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 64 Mexico Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 65 Mexico Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 66 Mexico Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 67 Mexico Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 68 Mexico Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 69 Mexico Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 70 Mexico Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 71 Rest of North America Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 72 Rest of North America Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 73 Rest of North America Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 74 Rest of North America Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 75 Rest of North America Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 76 Rest of North America Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 77 Rest of North America Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 78 Rest of North America Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 79 Key Information – Bio-Techne Corporation
TABLE 80 Key Information – Thermo Fisher Scientific, Inc.
TABLE 81 key Information – Merck GrouP
TABLE 82 Key Information – Bio-Rad Laboratories, Inc.
TABLE 83 key information – Abcam plc
TABLE 84 Key information – Genscript Biotech Corporation
TABLE 85 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 86 Key Information – Proteintech Group, Inc.
TABLE 87 Key Information – BPS Bioscience, Inc.
TABLE 88 Key Information – RayBiotech Life, Inc.
List of Figures
FIG 1 Methodology for the research